International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

BACKGROUND: Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting) is an o...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer-Westendorf, Jan, Camm, A. John, Fox, Keith A. A., Le Heuzey, Jean-Yves, Haas, Sylvia, Turpie, Alexander G. G., Virdone, Saverio, Kakkar, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482585/
https://www.ncbi.nlm.nih.gov/pubmed/31169831
http://dx.doi.org/10.1186/s12959-019-0195-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482585/
https://www.ncbi.nlm.nih.gov/pubmed/31169831
http://dx.doi.org/10.1186/s12959-019-0195-7

Ejemplares similares